VERA Vera Therapeutics Inc Gross Profit Rate

Corporate emblem and logo of Vera Therapeutics Inc (VERA)

Vera Therapeutics, Inc. (VERA) develops unique therapies for renal pathologies by focusing on specific proteins. This gross margin chart demonstrates financial efficiency, where the current metric is 56.60. Exclusive antibody rights and strict FDA oversight protect the business from competitors. Meanwhile, access to capital depends directly on clinical trial outcomes and the control of R&D costs.

veratx.com (VERA) Return on Gross Profit: for the period 07/04/2022 - 11/20/2026

Financial and market metric breakdowns for Vera Therapeutics, Inc. (VERA)

- stock value and consensus price forecast:
- cash position and cash flow details:
Fundamental valuation:VERA Vera Therapeutics Inc
Flagship merchandise of Vera Corp

Gross margin measures the portion of revenue remaining after deducting direct production costs, allowing for an assessment of the fundamental efficiency of profit generation per unit. For Vera Therapeutics, Inc. (VERA), which has no commercial products, the gross margin level reflects the profitability of partnership payments and investment inflows, focusing investor attention on the cost of maintaining R&D infrastructure prior to bringing drugs to market.

Main competitors

argenx - Gross Profit Rate|Gross Profitability biontech.de|ABIVAX (ABVX) - Return on Sales by Gross Profit|Gross Margin ADMA|Gross Profit Ratio PTGX|Gross Profitability Immunovant Corp IMVT|Gross Margin Kiniksa Pharmaceuticals, Ltd. KNSA|GRFS - Gross Profitability|Return on Sales by Gross Profit Adaptive Biotechnologies ADPT|CLDX (Celldex Therapeutics, Inc.) - Return on Gross Profit|Aurinia Pharmaceuticals Inc. (AUPH) - Gross Margin|Return on Gross Profit BCRX|Dianthus Pharma (DNTH) - Return on Sales by Gross Profit|Gross Profitability Pharvaris Pharma (PHVS)|Gross Margin AbCellera Corp (ABCL)|Gross Margin TRML (Tourmaline Bio Inc)|Return on Sales by Gross Profit precigen.com (PGEN)|PHAR - Gross Profitability|Gross Profit Rate NKTR (Nektar Therapeutics Inc.)|UPB (Upstream Bio Corp) - Return on Gross Profit|Zenas Corp (ZBIO) - Gross Margin|Return on Gross Profit IMNM|GOSS: Gross Profit Rate|Gross Profitability KalVista Pharma (KALV)|SEPN - Gross Profit Margin|Gross Margin PVLA (pieris.com)|Gross Margin Savara Pharma SVRA|RIGL: Return on Gross Profit|ANAB - Gross Margin|ATXS: Gross Margin|ENGN - Return on Sales by Gross Profit|Return on Gross Profit RAPT|JBIO (Aerovate Therapeutics Inc) - Gross Profit Ratio|Gross Margin ACRS|Return on Gross Profit kyvernatx.com KYTX|Gross Margin TLSA (Tiziana Life Sciences, Ltd.)|Gross Margin Cabaletta Bio CABA|VTYX: Return on Gross Profit|Theratechnologies Inc. (THTX) - Return on Gross Profit|AVTX: Gross Margin|ELDN - Return on Sales by Gross Profit|AGEN (Agenus, Inc) - Gross Margin|Gross Margin Climb Bio, Inc.|Gross Profitability Zura Bio Limited (ZURA)|ATYR (aTyr Pharmaceuticals) - Gross Profit Rate|Gross Margin ADAG (Adagene Inc)|IMA - Return on Gross Profit|STTK - Gross Profitability|EQ (equilliumbio.com) - Gross Return on Sales|CNTB: Gross Margin|Immunic Inc (IMUX) - Gross Margin|ATRA (Atara Biotherapeutics Inc) - Gross Margin|Gross Return on Sales IFRX (InflaRx N.V.)|x4pharma.com (XFOR) - Gross Profit Rate|Adicet Bio, Inc. - Gross Return on Sales|Celularity Inc - Return on Gross Profit|Gross Margin INmune Bio Corporation INMB|Barinthus Biotherapeutics - Gross Margin|Kezar Life Sciences, Inc. (KZR) - Return on Gross Profit|SAB Biotherapeutics Inc. (SABS) - Gross Profitability|Return on Gross Profit Akari Therapeutics plc|Gross Profitability enlivex.com|q32bio.com (QTTB) - Return on Sales by Gross Profit|Gross Margin GOVX|Edesa Biotech, Inc. - Gross Return on Sales|iBio Inc - Return on Gross Profit|Gross Margin Carisma Therapeutics CARM|XTLB - Gross Profitability|BOLT (boltbio.com) - Gross Return on Sales|HCWB: Gross Margin|Aptevo (APVO) - Gross Margin|Gross Profitability AIM ImmunoTech|Return on Gross Profit Aditxt (ADTX)|Return on Gross Profit GRI (GRI Bio Corporation)|XORTX - Gross Return on Sales|Gross Margin HIND (Vyome Holdings Inc.)|Gross Profit Rate REVB|Indaptus - Gross Margin|SCNI (Scinai Immunotherapeutics Ltd.) - Gross Return on Sales|CALI: Gross Margin|Affimed NV - Gross Profit Rate|Gross Profitability Allakos Inc.|Gross Margin HOOKIPA Pharma|Gross Profitability IGM Biosciences, Inc. (IGMS)|ITOS - Gross Profit Margin|Gross Margin OCEA (Ocean Bio)|Gross Profit Rate TCBP|THRD - Gross Profitability